Journals / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 12

Comparison of surgery and surgery plus corticosteroid therapy in idiopathic granulomatous mastitis, prospective randomized study

Pages
2984–2989
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

During follow-up, recurrencewas seen in one patient (6.7%) in surgery group and in 3 patients (20%) in steroid group but no significant difference was detectedbetween groups (p>0.05).Conclusion: In patients with granulomatous mastitis, systemic steroid therapy is an effective modality in patients unresponsive toantibiotic therapy after ruling out tuberculosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To compare therapeutic effectiveness of surgery alone with surgery plus corticosteroid in patients with granulomatous mastitis.Material and Methods: The study included 30 patients aged 23-60 years.
📊
Key Findings & Data:In-group 1, the patients received 375 mg ampicillin-sulbactam (twice daily, p.o.) for a week; than 32 mg prednisolone wasstarted which was gradually tapered (biweekly by 8 mg) over 8 weeks.
💡
Conclusion & Impact:During follow-up, recurrencewas seen in one patient (6.7%) in surgery group and in 3 patients (20%) in steroid group but no significant difference was detectedbetween groups (p>0.05).Conclusion: In patients with granulomatous mastitis, systemic steroid therapy is an effective modality in patients unresponsive toantibiotic therapy after ruling out tuberculosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To compare therapeutic effectiveness of surgery alone with surgery plus corticosteroid in patients with granulomatous mastitis.Material and Methods: The study included 30 patients aged 23-60 years. The patients were randomly assigned into two groupsby lot. In-group 1, the patients received 375 mg ampicillin-sulbactam (twice daily, p.o.) for a week; than 32 mg prednisolone wasstarted which was gradually tapered (biweekly by 8 mg) over 8 weeks. Surgery was performed 2 weeks after tapering. In-group 2,the patients received 375 mg ampicillin-sulbactam (twice daily, p.o.) for a week and underwent surgery. During 2-years follow-up, allpatients were assessed for etiological factors and recurrence.Results: No significant differences was found in demographic characteristics, smoking habits, oral contraceptive use, presentingcomplaints, physical examination findings, localization and diagnostic tools used between groups. During follow-up, recurrencewas seen in one patient (6.7%) in surgery group and in 3 patients (20%) in steroid group but no significant difference was detectedbetween groups (p>0.05).Conclusion: In patients with granulomatous mastitis, systemic steroid therapy is an effective modality in patients unresponsive toantibiotic therapy after ruling out tuberculosis.

🔖

Cite This Article

PATMANO, M., AKCAN, A., DOĞAN, S., GÜN, İ., SÖZÜER, E., ÖZ, A. B., ARIKAN, T. B. (2022). Comparison of surgery and surgery plus corticosteroid therapy in idiopathic granulomatous mastitis, prospective randomized study. Annals of Medical Research, Cilt: 26 - Sayı: 12, 2984–2989. https://ajindex.com/articles/446947

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist 2006;11:435-49
  2. Altıntoprak F, Baytekin HF, Altınay AE, et al. Meme Kanserini Taklit Eden İdiyopatik Granülomatöz Mastit. Meme Sağlığı Dergisi 2009;5:40-3
  3. Memis A, Bilgen I, Ustun EE, et al. Granulomatous mastitis: imaging findings with histopathologic correlation. Clinical Radiology, 2002;57:1001-6
  4. Bakaris S, Yuksel M, Cιragil P, et al. Granulomatous mastitis including breast tuberculosis and idiopathic lobular granulomatous mastitis. Canadian J Surgery, 2006;49:427
  5. Vinayagam R, Cox J, Webb L. Granulomatous mastitis: a spectrum of disease. Breast Care 2009;4:251-4
  6. Bani-Hani KE, Yaghan RJ, Matalka II, et al. Idiopathic granulomatous mastitis: time to avoid unnecessary mastectomies. Breast J 2004;10:318-22
  7. Yanık B, Gümüş M, Sak SD, et al. İdiyopatik granülomatöz mastit: görüntüleme bulguları. Tanısal ve Girişimsel Radyoloji 2002;8:372-6
  8. Al-Khaffaf B, Knox F, Bundred NJ. Idiopathic granulomatous mastitis: a 25-year experience. J American College of Surgeons 2008; 206:269-73
  9. Atalay C, Kızıltan G, Özaslan C, et al Idiopathic granulomatous mastitis. J Breast Health 2011;7:203- 6
  10. Pereira FA, Mudgil AV, Macias ES, et al. Idiopathic granulomatous lobular mastitis. International J Dermatology 2012;51:142-51
  11. Diesing D, Axt-Fliedner R, Hornung D, Weiss JM, Diedrich K, Friedrich M. Granulomatous mastitis. Archives Gynecology and Obstetrics 2004; 269: 233- 6
  12. Salam M, Alhomsi M, Daniel M, et al. Diagnosis and treatment of granulomatous mastitis. British J Surgery 1995;82:214
  13. Kamal RM, Hamed ST, Salem DS. Classification of inflammatory breast disorders and step by step diagnosis. The Breast J 2009;15:367-80
  14. Ünal G. Memenin cerrahi anatomisi. Meme Hastalıkları. Ünal G, Ünal H, Nobel Tıp Kitapevleri, İstanbul 2001;19-23
  15. Basu A, Khan D, De U, et al. Rare and interesting case of primary mammary tuberculosis mimicking breast carcinoma. Hellenic J Surgery 2013;85:337-41
  16. Tewari M, Shukla HS. Breast tuberculosis: diagnosis, clinical features & management. Indian J Medical Res 2005;122:103
  17. Akçay MN, Sağlam L, Polat P, et al. Mammary tuberculosis–importance of recognition and differentiation from that of a breast malignancy: report of three cases and review of the literature. World J Surgical Oncology 2007;5: 67
  18. Altintoprak F. Topical steroids to treat granulomatous mastitis: a case report. The Korean J Inte